SALT LAKE CITY, July 15, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced it has received the Great Place to Work Certification for the third year in a row. The certification is based entirely on what current employees say about their experience working at Myriad. This year, 84% of employees said Myriad Genetics is a Great Place To Work โ 30 percentage points higher than the average U.S. company.
โOur focus on inclusivity and caring makes this a great place to work,โ shared a current Myriad Genetics employee in the survey. โOur employee resource groups give employees a place to connect with employees like them, an opportunity to share their struggles and successes, and a community to support them.โ
Great Place To Workยฎ is the global authority on workplace culture, employee experience, and the leadership behaviors proven to deliver market-leading revenue, employee retention and increased innovation.
โAt Myriad Genetics, our teammates are critical to achieving our shared mission of advancing health and well-being for all,โ said Shereen Solaiman, chief people officer, Myriad Genetics. โWe are honored to be recognized as a Great Place to Work for the third year in a row. This certification reflects the passion and dedication of our teammates, who are committed to building a workplace where every teammate feels connected, supported, and empowered to make a difference.โ
"Great Place To Work Certification is a highly coveted achievement that requires consistent and intentional dedication to the overall employee experience," says Sarah Lewis-Kulin, the Vice President of Global Recognition at Great Place To Work. She emphasizes that Certification is the sole official recognition earned by the real-time feedback of employees regarding their company culture. โBy successfully earning this recognition, it is evident that Myriad Genetics stands out as one of the top companies to work for, providing a great workplace environment for its employees."
Visit our careers page to explore open roles and learn more about what itโs like to work at Myriad.
About Great Place to Work Certificationโข
Great Place To Workยฎ Certificationโข is the most definitive โemployer-of-choiceโ recognition that companies aspire to achieve. It is the only recognition based entirely on what employees report about their workplace experience โ specifically, how consistently they experience a high-trust workplace. Great Place to Work Certification is recognized worldwide by employees and employers alike and is the global benchmark for identifying and recognizing outstanding employee experience. Every year, more than 10,000 companies across 60 countries apply to get Great Place To Work-Certified.
About Great Place To Workยฎ
As the global authority on workplace culture, Great Place To Workยฎ brings 30 years of groundbreaking research and data to help every place become a great place to work for all. Their proprietary platform and For Allโข Model helps companies evaluate the experience of every employee, with exemplary workplaces becoming Great Place To Work Certifiedโข or receiving recognition on a coveted Best Workplacesโข List.
Learn more at greatplacetowork.com and follow Great Place To Work on LinkedIn, Twitter, Facebook and Instagram.
About Myriad Geneticsย
Myriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad Genetics develops and offers molecular tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.
Safe Harbor Statement
This press release contains โforward-looking statementsโ within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to Myriadโs commitment to building a workplace where every teammate feels connected, supported, and empowered to make a difference. These โforward-looking statementsโ are managementโs expectations of future events as of the date hereof and are subject to known and unknown risks and uncertainties that could cause actual results, conditions, and events to differ materially and adversely from those anticipated. Such factors include those risks described in the companyโs filings with the U.S. Securities and Exchange Commission, including the companyโs Annual Report on Form 10-K filed on February 28, 2025, as well as any updates to those risk factors filed from time to time in the companyโs Quarterly Reports on Form 10-Q or Current Reports on Form 8-K. Myriad is not under any obligation, and it expressly disclaims any obligation, to update or alter any forward-looking statements, whether as a result of new information, future events or otherwise except as required by law.ย
Investor Contactย
Matt Scaloย
(801) 584-3532ย
IR@myriad.comย
Media Contactย
Kate Schraml
(224) 875-4493
PR@myriad.comย ย
